Categories
- Aesthetic Medicine
- Aesthetic Surgery
- Ai
- ALS Treatment
- Anatomy
- Artificial General Intelligence
- Artificial Intelligence
- Artificial Super Intelligence
- Batten Disease Treatment
- BioEngineering
- BioInformatics
- Biology
- Biotechnology
- Bitcoin
- Brain Injury Treatment
- Cardiac Nursing
- Cardiac Regeneration
- Cardiac Remodeling
- Cardiac Rhythm Abnormalities
- Cardiac Surgery
- Cardiology
- Cardiomyopathies
- Cardiovascular Pharmacology
- Cell Medicine
- Cell Therapy
- Cerebral Palsy
- Cerebral Palsy Treatment
- Cheap Pharmacy
- Chemistry
- Clinical Cardiology
- Coronary Heart Diseases
- Cryptocurrency
- DNA
- Drug Dependency
- Drug Side Effects
- Drugs
- Eczema
- Elon Musk
- Embryology
- Erectile Dysfunction
- FDA Stem Cell Trials
- Femtomedicine
- Future Medicine
- Gene Medicine
- Gene Therapy
- Gene Therapy Trials
- Genetic Engineering
- Genetic Therapy
- Genetics
- Germ Line Engineering
- Heart Diseases
- HGH
- Hgh Injections
- Hormone Replacement Therapy
- Human Genetics
- Human Growth Hormone
- Human Immortality
- Hyperbaric Medicine
- Hypertension
- Hypothalamus
- Impotency
- Internet Pharmacy
- Interventional Cardiology
- IVF Treatment
- Lyme Disease
- Male Sexual Dysfunction
- Mars Colony
- Medical Business
- Medical School
- Medical Technology
- Medicine
- Mental Health
- Mesenchymal Stem Cells
- Micropenia
- Molecular Cardiology
- MS Treatment
- Muscular Dystrophy Treatment
- Myocardial Infarction
- Nanotechnology
- Online Pharmacy
- Oral Health
- Parkinson's Treatment
- Pediatric Cardiology
- Penis Enlargement
- Pet Stem Cell Therapy
- Pharmacy
- Picomedicine
- Premature Ejaculation
- Prescriptions
- Retinitis Pigmentosa
- Sermorelin
- Singularity
- Sleep
- Spacex
- Spinal Cord Injury Treatment
- Stem Cell Clinical Trials
- Stem Cell Experiments
- Stem Cell Human Trials
- Stem Cell Injections
- Stem Cell Research
- Stem Cell Transplant
- Stem Cell Treatments
- Testosterone
- Ulcerative Colitis
- Uncategorized
- Vascular Biology
- Ventricular Remodeling
- Wholesale Pharmacy
Archives
Category Archives: MS Treatment
A vision of a world free from the effects of multiple sclerosis – Open Access Government
Posted: Published on November 22nd, 2020
Over 130,000 people live with multiple sclerosis (MS) in the UK, and a diagnosis can have a profound impact. Continue reading
Posted in MS Treatment
Comments Off on A vision of a world free from the effects of multiple sclerosis – Open Access Government
Increasing Progenitor Cell Proliferation in the Sub-Ventricular Zone: A Therapeutic Treatment for Progressive Multiple Sclerosis? – DocWire News
Posted: Published on November 22nd, 2020
Recent Pat Drug Deliv Formul. 2020 Nov 17. doi: 10.2174/1872211314999201117130123 Continue reading
Posted in MS Treatment
Comments Off on Increasing Progenitor Cell Proliferation in the Sub-Ventricular Zone: A Therapeutic Treatment for Progressive Multiple Sclerosis? – DocWire News
Early Treatment Improvements in Depression Are Associated With Overall Improvements in Fatigue Impact and Pain Interference in Adults With Multiple…
Posted: Published on November 22nd, 2020
This article was originally published here Ann Behav Med. 2020 Nov 16:kaaa102. doi: 10.1093/abm/kaaa102 Continue reading
Posted in MS Treatment
Comments Off on Early Treatment Improvements in Depression Are Associated With Overall Improvements in Fatigue Impact and Pain Interference in Adults With Multiple…
Officials: New COVID-19 cases shifting toward younger Mississippians; vaccines on the way – Clarion Ledger
Posted: Published on November 22nd, 2020
More promising news on the vaccine front: Moderna says its vaccine provides strong protection against COVID-19. Continue reading
Posted in MS Treatment
Comments Off on Officials: New COVID-19 cases shifting toward younger Mississippians; vaccines on the way – Clarion Ledger
GW Pharma shares rally on earnings and news of late-stage trial of cannabis-based treatment for MS patients – MarketWatch
Posted: Published on November 9th, 2020
Shares of GW Pharmaceuticals PLC jumped 18% Tuesday, after the biotech posted a narrower-than-expected third-quarter loss and a revenue beat and said a delayed late-stage trial of its cannabinoid-based treatment for multiple sclerosis spasticity can now proceed. Volume of 2.14 million shares traded was 5.5 times the 65-day average of 385,930. GW Pharma GWPH, +2.41% is the first company to win U.S. Continue reading
Posted in MS Treatment
Comments Off on GW Pharma shares rally on earnings and news of late-stage trial of cannabis-based treatment for MS patients – MarketWatch
Hydroxychloroquine does not benefit adults hospitalized with COVID-19 – National Institutes of Health
Posted: Published on November 9th, 2020
News Release Monday, November 9, 2020 A National Institutes of Health clinical trial evaluating the safety and effectiveness of hydroxychloroquine for the treatment of adults with coronavirus disease 2019 (COVID-19) has formally concluded that the drug provides no clinical benefit to hospitalized patients. Though found not to cause harm, early findings in June when the trial was stopped indicated that the drug was not improving outcomes in COVID-19 patients Continue reading
Posted in MS Treatment
Comments Off on Hydroxychloroquine does not benefit adults hospitalized with COVID-19 – National Institutes of Health
Informative video series launched to support people living with secondary progressive MS – Offaly Express
Posted: Published on November 9th, 2020
MS Ireland and Novartis have launched a new video series entitled SPMS Explained,which aims to support those living with secondary progressive multiple sclerosis (SPMS) in Ireland. People with SPMS are typically diagnosed after 10 to 20 years living with relapsing remitting MS (RRMS) and studies indicate that 50% of those diagnosed with RRMS will transition to SPMS within 10 years, and 90% will transition within 25 years. SPMS symptoms do not go away completely after a relapse or flare-up and there is a steady increase in disability Continue reading
Posted in MS Treatment
Comments Off on Informative video series launched to support people living with secondary progressive MS – Offaly Express
Merck Announces Out-Licensing Agreement for Investigational Atacicept with Vera Therapeutics – PR Newswire India
Posted: Published on November 9th, 2020
Not intended for UK and US based media -Merck out-licenses Phase IIb-ready atacicept to Vera Therapeutics - Phase IIa trial conducted by Merck shows promising results in IgA nephropathy (IgAN), also known as "Berger's disease" - Out-licencing deal includes 10% equity in Vera Therapeutics and up to 605 million in development and commercial milestones, plus royalties on any future net sales DARMSTADT, Germany, Nov. Continue reading
Posted in MS Treatment
Comments Off on Merck Announces Out-Licensing Agreement for Investigational Atacicept with Vera Therapeutics – PR Newswire India
Therapeutic Role of Inflammasome Inhibitors in Neurodegenerative Disorders – DocWire News
Posted: Published on November 9th, 2020
This article was originally published here Brain Behav Immun. 2020 Nov 3:S0889-1591(20)32378-3. doi: 10.1016/j.bbi.2020.11.004. Continue reading
Posted in MS Treatment
Comments Off on Therapeutic Role of Inflammasome Inhibitors in Neurodegenerative Disorders – DocWire News
Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWAS – DocWire News
Posted: Published on November 9th, 2020
This article was originally published here BMC Med. 2020 Nov 4;18(1):298. doi: 10.1186/s12916-020-01769-6. Continue reading
Posted in MS Treatment
Comments Off on Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWAS – DocWire News